Eisai and Pfizer are to try once again to reverse NICE restrictions on Alzheimer’s drugs by appealing against the recent …
Novartis has received a "not approvable" letter from the FDA for its painkiller Prexige because of concerns about potential liver …
Roche has announced that it is to cut the price of its lung cancer treatment Tarceva for a limited time …
Cubicin approved for marketing in CanadaCubist Pharmaceuticals has said that Health Canada has approved Cubicin for marketing in Canada, where …
When it comes to filling the most senior roles in a company, whatever its size, executive search is, more often …
Patients with multiple sclerosis could benefit from a drug currently used to treat leukaemia, with late-stage trials now commencing.Discovered by …
The MS Society has launched a campaign to raise awareness of multiple sclerosis and the help the patient group can …
Regulators, the pharma industry and academic institutions are to come together in a new global alliance to research drug side-effects. …
mXm Medical Communications has launched a new tool to measure the return on investment from communications activities at medical meetings.Its …
Recent government proposals to centralise London healthcare have met resistance among GPs. Independent trade union for doctors, the British Medical …
Bristol-Myers Squibb has significantly advanced its strategy to move into biologics with the acquisition of US biotech Adnexus.The $430 million …
Alnylam and Merck end collaborationBiopharmaceutical company Alnylam Pharmaceuticals and Merck & Co. have mutually agreed to terminate their July 2006 …
How clinical research is organised in the UK is essential to the success of Britain's pharma industry, and to the …
Deciding which aspects of a global brand should be defined centrally and how much freedom there is in any given …
GlaxoSmithKline's cervical cancer vaccine Cervarix has been approved in Europe, setting it up for a head-to-head clash with Sanofi-Pasteur MSD's …
Pfizer's Celsentri has been approved in Europe, making it the first in a new, oral class of HIV drugs in …
The Prime Minister has outlined his plans to provide NHS patients with a more personalised service fit for the 21st …
AstraZeneca has denied it plans to outsource its drug manufacturing requirements by 2017, following comments made by a senior board …
Takeda says new data on its diabetes drug Actos shows a number of safety advantages over GSK's rival product Avandia.Two …
Hilary Clinton has unveiled plans to introduce universal healthcare insurance in America as part of her campaign to become US …